Artelo Biosciences Inc (ARTL)

NASDAQ HEALTHCARE
$1.26 -0.79% RSI 32 Neutral Add Alert

Moving Averages

SMA 200
$6.90
Price below

Company Profile

Artelo Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. The company is headquartered in La Jolla, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$4.74M
P/E Ratio
None
EPS
$-29.01
Beta
0.049
Dividend Yield
0.00%
52-Week High
$85.8
52-Week Low
$1.19

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 49.0
VRTX
Vertex Pharmaceuticals Inc
RSI 56.0
CRSP
CRISPR Therapeutics AG
RSI 55.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 49.0
MRNA
Moderna Inc
RSI 75.0
VKTX
Viking Therapeutics Inc
RSI 51.0
SRPT
Sarepta Therapeutics Inc
RSI 54.0
EDIT
Editas Medicine Inc
RSI 48.0
IOVA
Iovance Biotherapeutics Inc
RSI 50.0
NVAX
Novavax Inc
RSI 48.0

Data last updated: June 13, 2026 at 9:03 AM EDT

Track ARTL for free

Get e-mail RSI alerts when Artelo Biosciences Inc enters oversold or overbought territory. Free forever.

Add Alert